U.S. Senator John Fetterman (D-PA) has strongly criticized recent Trump administration policies that could compromise the ...

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

Fetterman's Small Donor Revolt Highlights Betrayal of Grassroots Support** In a stunning turn of events for the Democratic Party, Senator John Fetterman of Pen ...

The FDA warned that several hundred units of counterfeit 1-mg semaglutide (Ozempic) were found in the U.S. drug supply chain ...

Local party chair’s demand for Senator Fetterman to step down raises questions about what truly constitutes Democratic ...

John Fetterman urged Trump to reverse his decision to pull a Biden-era proposal that would have made GLP-1 medications more ...

In a New York Times op-ed on April 8, Sen. John Fetterman, D-Pa., wrote about his experience with Mounjaro (tirzepatide). The ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

As the survivor of a stroke, U.S. Sen. John Fetterman, D-Pennsylvania, writes about the effectiveness of the medication ...

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...

Senator John Fetterman (D-PA) revealed he’s using a weight loss drug and is now asking the Trump Administration to make it ...

Senator John Fetterman, a democrat from Pennsylvania, admitted to using weight loss drug Mounjaro and issued a desperate plea ...